ImmuCell

ImmuCell Net Change in Cash

The Net Change in Cash of ImmuCell (ICCC) as of Nov 3, 2026 is 48,599.00 USD. In the previous year, Net Change in Cash was 2.78 M USD — a change of -98.25% (lower).

Net Change in Cash

48,599.00USD

YoY

-98.25%

Last updated:

Net Change in Cash of ImmuCell is 2025 48,599.00 USD. Net Change in Cash of ImmuCell was 2024 2.78 M USD. It decreases by -98.25% lower compared to the previous year.

The ImmuCell Net Change in Cash history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Change in Cash
Date
Net Change in Cash
Jan 1, 2018
-1.28 M USD
Jan 1, 2019
3.77 M USD
Jan 1, 2020
656,644.00 USD
Jan 1, 2021
3.24 M USD
Jan 1, 2022
-4.39 M USD
Jan 1, 2023
-4.81 M USD
Jan 1, 2024
2.78 M USD
Jan 1, 2025
48,599.00 USD
The ImmuCell Net Change in Cash history
YEARNet Change in CashYoY
48,599.00USD-98.25%
2.78 MUSD-157.75%
-4.81 MUSD+9.53%
-4.39 MUSD-235.80%
3.24 MUSD+392.74%
656,644.00USD-82.59%
3.77 MUSD-395.22%
-1.28 MUSD-5.46%
-1.35 MUSD-137.78%
3.58 MUSD+394.54%
723,300.00USD-150.92%
-1.42 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

ImmuCell Stock analysis

What does ImmuCell do? ImmuCell Corp is an American company that specializes in the development and marketing of veterinary products for the ruminant industry. It was originally founded in the late 1970s under the name PrioGene and initially focused on the development of diagnostics for tuberculosis and brucellosis in cattle. In the 1990s, the company changed its name to ImmuCell and shifted its focus to the development of products to support animal health. ImmuCell's business model is centered around the development, manufacturing, and sale of products to improve animal health. They offer a wide range of veterinary products, including immunoassays, vaccines, antibiotics, and complementary feeds. The company aims to improve animal health with minimal impact on the environment and works closely with veterinarians and industry experts. They have divisions dedicated to diagnostics, vaccines, and antibiotics, and their products can help identify and prevent diseases in livestock. Notable products include the LBC mastitis diagnostic and the Immu-PRIME spray for preventing umbilical infections in newborn calves. ImmuCell has established itself as a leading innovator in the animal health industry and has conducted clinical studies on the efficacy of their HO-VAX product. In conclusion, ImmuCell focuses on developing and marketing products to support animal health, with a commitment to improving the well-being of livestock. ImmuCell is one of the most popular companies on Eulerpool.

Frequently Asked Questions about ImmuCell stock

Net Change in Cash of ImmuCell is 48,599.00 USD in 2025.

Net Change in Cash of ImmuCell changed from 2.78 M USD to 48,599.00 USD, representing a -98.25% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Net Change in Cash ImmuCell since 2006 – with annual values, charts, and detailed analysis.

Net change in cash is the total change in cash and equivalents during the period, combining operating, investing, and financing cash flows.

Net Change in Cash's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Net Change in Cash's ImmuCell historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — ImmuCell

All Key Metrics — ImmuCell